Viewing nowCombinationDiseden Plus Tablet
Risedronate Sodium 2.5 Hydrate 40.162mg · Cholecalciferol Concentrate Powder 56mg
Tablet · Prescription medication · Combination
Eden Pharma Co., Ltd.

MFDS item code 201700405 · Approved 2017.01.23 · Insurance code 628900800
Treatment of osteoporosis in postmenopausal women and men; prevention of postmenopausal osteoporosis
This medication is used to treat and prevent osteoporosis in both postmenopausal women and men.
Adults: Administer 1 tablet of this medicine orally once weekly. Elderly patients: No dose adjustment is necessary in elderly patients (60 years or older), because the bioavailability and pharmacokinetics of this medicine are similar to those in younger people. Patients with renal impairment: No dose adjustment is necessary in patients with creatinine clearance of 30ml/min or higher. This medicine is contraindicated in patients with severe renal impairment and creatinine clearance below 30ml/min. Since food interferes with the absorption of this medicine, take it as follows to ensure adequate absorption. Take it at least 30 minutes before breakfast, or at any time of day at least 2 hours before or after eating food or drinking beverages. Take this medicine in an upright position with a sufficient amount of plain water (170 ~ 230ml) to help it reach the stomach and reduce the possibility of esophageal irritation. Taking this medicine with other beverages, including mineral water, may reduce its absorption. Do not chew or suck this medicine because of the possibility of oropharyngeal ulceration. Patients should also remain upright for at least 30 minutes after taking this medicine. Patients should take supplements if their dietary intake of calcium and vitamin D is insufficient. Patients at increased risk of vitamin D deficiency (e.g., patients over 70 years of age, patients in nursing homes, and patients with chronic diseases) may need additional vitamin D supplementation. Patients with gastrointestinal malabsorption syndromes may require higher doses of vitamin D supplements, and measurement of 25-hydroxyvitamin D levels should be considered. The recommended daily intake of vitamin D is 400 IU to 800 IU. Once-weekly administration of this medicine provides one week's supply of vitamin D at 800 IU daily. If a patient forgets to take a dose on the scheduled day, they should take it on the day they remember. The next dose should be taken on the originally scheduled dosing day. Do not take 2 tablets on the same day.
The safety and efficacy in children and growing adolescents have not been established.
This medication may irritate the gastrointestinal mucosa, potentially resulting in adverse esophageal reactions such as esophagitis, esophageal ulcers, and esophageal stricture. It should be taken with a sufficient amount of water (170-230 ml), and the patient should remain upright for at least 30 minutes after taking it. If symptoms such as dysphagia, odynophagia, retrosternal pain, or heartburn occur, discontinue use immediately and consult a physician. Patients with esophageal motility disorders or severe renal impairment should not take this medication. This medication contains lactose, so patients with lactose intolerance should avoid taking it. Calcium and vitamin D deficiencies must be treated prior to use, and supplementation may be necessary if needed. Patients who have dental surgery or oral infections should be cautious due to the risk of osteonecrosis of the jaws. When taking bisphosphonate medications, there may be rare occurrences of worsening bone, joint, and muscle pain; consult a physician if these symptoms arise. Taking this medication with other calcium, magnesium, iron, aluminum-containing drugs or food may interfere with absorption, so it should be taken at a time interval. Women who are pregnant or breastfeeding should avoid taking this medication or consult a doctor. Safety and efficacy in pediatric patients have not been established, while elderly patients may use it without special precautions. Overdose may lead to hypocalcemia, and immediate treatment should be sought if symptoms arise. This medication should be stored out of the reach of children, and it is advisable not to transfer it to other containers.
esophagitis, esophageal ulcer, esophageal erosion, esophageal obstruction, perforation, bleeding, gastric ulcer, duodenitis, glossitis, abnormal results of various functional tests, decreased blood calcium, decreased blood phosphorus, infection, low back pain, pain, abdominal pain, neck pain, weakness, chest pain, neoplasm, hernia, hypertension, cardiovascular disease, angina, nausea, diarrhea, bloating, gastritis, gastrointestinal diseases, rectal diseases, dental diseases, petechiae, anemia, arthralgia, joint abnormalities, myalgia, bone pain, bone abnormalities, leg cramps, bursitis, tendinopathy, depression, dizziness, insomnia, anxiety, neuralgia, vertigo, tension, sensory abnormalities, pharyngitis, rhinitis, dyspnea, pneumonia, rash, itching, skin cancer, cataract, conjunctivitis, otitis media, urinary tract infection, cystitis, injuries due to accidents, flu syndrome, headache, overdose, allergic reactions, tumors, syncope, vasodilation, constipation, dyspepsia, nausea, gastroenteritis, colitis, vomiting, polydipsia, peripheral edema, traumatic fracture, myalgia, arthritis, headache, dizziness, bronchitis, sinusitis, increased cough, chest discomfort, palpitations, increased sweating, facial flushing, burning sensation, nephrolithiasis, belching, hematuria, fever, edema, hair loss, dysosmia, Stevens-Johnson syndrome, toxic epidermal necrolysis, angioedema, blister, jawbone necrosis, liver function impairment, jaundice, external auditory canal osteonecrosis, hypocalcemia, hypercalcemia, hypercalciuria, anorexia, polyuria, weakness, somnolence, polydipsia
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air and moisture; therefore, it should be stored in a tightly sealed container. It is best to keep the temperature between 1 degree and 30 degrees Celsius at room temperature to safely preserve the effectiveness of the medication.
Light orange oval film-coated tablet
4 tablets/PTP
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationRisedronate Sodium 2.5 Hydrate 40.162mg · Cholecalciferol Concentrate Powder 56mg
Tablet · Prescription medication · Combination
Eden Pharma Co., Ltd.
CombinationRisedronate Sodium 2.5 Hydrate 40.162mg · Cholecalciferol Concentrate Powder 56mg
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
CombinationRisedronate Sodium 2.5 Hydrate 40.162mg · Cholecalciferol Concentrate Powder 56mg
Tablet · Prescription medication · Combination
Hanlim Pharmaceutical Co., Ltd.
CombinationRisedronate Sodium 2.5 Hydrate 40.162mg · Cholecalciferol Concentrate Powder 56mg
Tablet · Prescription medication · Combination
Hanin Pharmaceutical Co., Ltd.
CombinationRisedronate Sodium 2.5 Hydrate 40.162mg · Cholecalciferol Concentrate Powder 56mg
Tablet · Prescription medication · Combination
Dongkuk Pharmaceutical Co., Ltd.
CombinationRisedronate Sodium 2.5 Hydrate 40.162mg · Cholecalciferol Concentrate Powder 56mg
Tablet · Prescription medication · Combination
Yu Young Pharmaceutical Co., Ltd.
CombinationRisedronate Sodium 2.5 Hydrate 40.162mg · Cholecalciferol Concentrate Powder 56mg
Tablet · Prescription medication · Combination
Korea Prime Pharmaceutical Co., Ltd.
CombinationRisedronate Sodium 2.5 Hydrate 40.162mg · Cholecalciferol Concentrate Powder 56mg
Tablet · Prescription medication · Combination
Allico Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.